drugset / Trial / NCT01891292

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

NCT01891292

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether enalapril or antioxidant therapy (N-Acetylcysteine) is effective in reducing microalbuminuria in children with sickle cell disease and and its progression to sickle nephropathy

Timeline

Start
2013-07
Primary completion
2014-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enalapril Other / unclassified
Comparator N-acetylcysteine Small molecule 0.5 unknown